Sigve Andersen - Concepedia

Author

Sigve Andersen

UiT The Arctic University of Norway ORCID

Also Known As

Andersen, Sigve, S. Andersen, S.A. Andersen, SIGVE ANDERSEN, Sigve Andersen

117

Publications

5.4K

Citations

H-Index

Concepts

All Affiliations

UiT The Arctic University of Norway University Hospital of North Norway Nordland Hospital University of Oslo Oslo University Hospital

About

Sigve Andersen is an author at UiT The Arctic University of Norway specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	21	951
2	Cell Biology	7	7	364
3	Immunology	4	4	219
4	Engineering	1	1	18
5	Health Sciences	1	1	100

Sigve Andersen

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer Tom Dønnem, Sigurd M. Hald, Erna‐Elise Paulsen, Clinical Cancer Research	2015	327
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry Mehrdad Rakaee, Lill-Tove Rasmussen Busund, Simin Jamaly, Neoplasia	2019	169
Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer Tom Dønnem, Sigve Andersen, Khalid Al‐Shibli, Cancer	2010	129
Association of Machine Learning–Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC Mehrdad Rakaee, Elio Adib, Biagio Ricciuti, JAMA Oncology	2022	123
Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer Nora Ness, Sigve Andersen, Andrej Valkov, The Prostate	2014	114
Prognostic Impact of Platelet-Derived Growth Factors in Non-small Cell Lung Cancer Tumor and Stromal Cells Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Journal of Thoracic Oncology Stromal CellsTumor BiologyPlatelet-derived Growth FactorsThrombopoiesisPrognostic Impact	2008	113
Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization Tom Dønnem, Katrine Eklo, Thomas Berg, Journal of Translational Medicine	2011	110
MicroRNA Signatures in Tumor Tissue Related to Angiogenesis in Non-Small Cell Lung Cancer Tom Dønnem, Christopher G. Fenton, Kenneth Lønvik, PLoS ONE	2012	103
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer Mehrdad Rakaee, Thomas K. Kilvær, Simin Jamaly, British Journal of Cancer Lymphoid NeoplasiaPromising ApproachSurgical OncologyTumor HeterogeneityMedicine	2021	100
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases Erna‐Elise Paulsen, Thomas K. Kilvær, Mehrdad Rakaee, Cancer Immunology Immunotherapy	2017	92

Page 1